Skip to main content

Amgen ownership: holders and insider trading

  • AMGN · Nasdaq
  • Biotechnology
  • S&P 500
$465.67−0.30%Close 13 Nov 2026 · Market value $253.3B

As filed, its directors and officers own 0.5% of the shares (proxy statement, 20 Mar 2026); 3,146 institutional managers reported holding 82.7% at 30 Jun 2026. Over the last twelve months, insiders sold $26.71M of shares on the open market, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
VanguardInstitution56.0M10.35%*Form 13F30 Jun 2026
BlackRockInstitution49.4M9.13%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder40.5M7.51%Schedule 13G31 Mar 2026
Capital GroupInstitution37.0M6.85%*Form 13F30 Jun 2026
State StreetInstitution30.6M5.65%*Form 13F30 Jun 2026
Capital World InvestorsHolder29.6M5.5%Schedule 13G31 Mar 2026
InvescoInstitution16.3M3.02%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution15.7M2.90%*Form 13F30 Jun 2026
Charles SchwabInstitution15.0M2.78%*Form 13F30 Jun 2026
Morgan StanleyInstitution13.7M2.52%*Form 13F30 Jun 2026
UBSInstitution8.7M1.61%*Form 13F30 Jun 2026
Wells FargoInstitution7.2M1.34%*Form 13F30 Jun 2026
Primecap Management CoInstitution6.8M1.25%*Form 13F30 Jun 2026
Northern TrustInstitution6.2M1.15%*Form 13F30 Jun 2026
Norges BankInstitution5.6M1.04%*Form 13F30 Jun 2026
Bank of AmericaInstitution5.1M0.94%*Form 13F30 Jun 2026
Royal Bank of CanadaInstitution4.3M0.80%*Form 13F30 Jun 2026
Goldman SachsInstitution4.1M0.76%*Form 13F30 Jun 2026
T. Rowe PriceInstitution4.0M0.73%*Form 13F30 Jun 2026
AmundiInstitution3.9M0.72%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Khosla Rachna · SVP, Business Development13 Aug 2026Open-market sale−1.3K$416.43$521.4K
Khosla Rachna · SVP, Business Development13 Aug 2026Option exercise+1.3K$162.60$203.6K
Khosla Rachna · SVP, Business Development11 Aug 2026Open-market sale−2.0K$412.57$825.1K
Busch Matthew C. · VP, Finance & CAO7 Aug 2026Grant or award+730——
ISHRAK OMAR · Director7 Aug 2026Grant or award+85——
HOLLEY CHARLES M · Director7 Aug 2026Grant or award+103——
Drake Michael V · Director7 Aug 2026Grant or award+64——
Miller Derek · SVP, Human Resources6 Aug 2026Open-market sale−2.1K$402.54$832.9K
Miller Derek · SVP, Human Resources6 Aug 2026Option exercise+2.1K$162.60$336.4K
Miller Derek · SVP, Human Resources6 Aug 2026Option exercise+1.8K$177.46$323.2K
Miller Derek · SVP, Human Resources6 Aug 2026Open-market sale−1.8K$402.54$733.0K
Grygiel Nancy A. · SVP & CCO6 Aug 2026Open-market sale−1.0K$402.16$402.2K
Grygiel Nancy A. · SVP & CCO6 Aug 2026Open-market sale−2.0K$402.16$792.3K
Grygiel Nancy A. · SVP & CCO6 Aug 2026Option exercise+2.0K$177.46$349.6K
Grygiel Nancy A. · SVP & CCO6 Aug 2026Option exercise+1.0K$177.31$177.3K
MILES AMY E · Director19 May 2026Grant or award+665——
Kullman Ellen Jamison · Director19 May 2026Grant or award+665——
Klotman Mary E. · Director19 May 2026Grant or award+665——
Jacks Tyler · Director19 May 2026Grant or award+665——
ISHRAK OMAR · Director19 May 2026Grant or award+665——
HOLLEY CHARLES M · Director19 May 2026Grant or award+665——
Garland Greg C. · Director19 May 2026Grant or award+665——
ECKERT ROBERT · Director19 May 2026Grant or award+665——
Druker Brian · Director19 May 2026Grant or award+665——
Drake Michael V · Director19 May 2026Grant or award+665——

Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

AMGN in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.